InTrack Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-332
Closed -$206K 126
2024
Q3
$206K Sell
332
-36
-10% -$21.3K 0.15% 119
2024
Q2
$204K Hold
368
0.14% 129
2024
Q1
$214K Sell
368
-50
-12% -$28.1K 0.16% 127
2023
Q4
$222K Sell
418
-2,103
-83% -$1.02M 0.17% 126
2023
Q3
$1.28M Buy
2,521
+89
+4% +$47.4K 1.12% 23
2023
Q2
$1.27M Buy
2,432
+1,985
+444% +$1.07M 1.04% 29
2023
Q1
$258K Hold
447
0.24% 109
2022
Q4
$246K Buy
+447
New +$237K 0.25% 106

Other funds holding TMO

InTrack Investment Management's TMO Position: Q4 2024 in Review

InTrack Investment Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 332 shares — an estimated $206K sold.

InTrack Investment Management first reported a position in TMO in Q4 2022 and held it in 8 quarters. The position peaked at $1.28M in Q3 2023. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • InTrack Investment Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • InTrack Investment Management sold 332 Thermo Fisher Scientific shares in Q4 2024, an estimated $206K.
  • InTrack Investment Management first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 8 quarters.
  • InTrack Investment Management's Thermo Fisher Scientific position peaked at $1.28M in Q3 2023.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on InTrack Investment Management's 13F filing for Q4 2024, filed 15 Jan 2025.